Copyright: ©Author(s) 2026.
World J Diabetes. Nov 15, 2026; 17(11): 125698
Published online Nov 15, 2026. doi: 10.4239/wjd.125698
Published online Nov 15, 2026. doi: 10.4239/wjd.125698
Table 5 Key numerical summary of model performance, calibration, and clinical utility
| Metric | XGBoost |
| Nested 5 × 5 cross-validation AUC | 0.746 ± 0.038 |
| Bootstrap optimism-corrected AUC | 0.745 |
| Calibration slope | 1.176-1.007 |
| Calibration intercept | -0.104 to -0.040 |
| Expected calibration error | 0.044 to 0.034 |
| Brier score (validation) | 0.186 |
| Split-ratio AUC (6:4/7:3/8:2) | 0.758/0.762/0.755 |
| PPV/NPV at threshold 0.5 | 0.737/0.607 |
| PPV/NPV at threshold 0.7 | 0.863/0.551 |
- Citation: Lv YW, Jiang AJ, Geng YM, Hu M, Wang YQ, Ma L, Shen N, Zhao JD. Integrating traditional Chinese medicine syndromes with clinical variables to predict lower extremity arterial disease in type 2 diabetes. World J Diabetes 2026; 17(11): 125698
- URL: https://www.wjgnet.com/1948-9358/full/v17/i11/125698.htm
- DOI: https://dx.doi.org/10.4239/wjd.125698